pharma · IgA Nephropathy · Rhematoid Arthritis · JBIO
Jade Biosciences
Jade Biosciences patent portfolio — 2 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Waltham, USA HQ
2024 Founded
72 Employees
Public company Type
JBIO · NYSE Ticker
Company details
- Status
- Public
- HQ
- Waltham, USA
- Founded
- 2024
- Employees
- 72
- Programs
- 4
- Drugs
- 1
- Patents
- 2
Jade Biosciences patents
2 pharmaceutical patents indexed for Jade Biosciences. 0 expire within 24 months.
Jade Biosciences has 2 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
Frequently asked questions
How many patents does Jade Biosciences have?
2 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Jade Biosciences patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.